000 | 01810cam a22004814a 4500 | ||
---|---|---|---|
005 | 20150712005527.0 | ||
008 | 030327s2004 njua b 001 0 eng | ||
010 | _a 2003020804 | ||
020 | _a0471601500 | ||
035 | _a(DNLM)101191700 | ||
040 |
_aDNLM/DLC _cDLC _dDLC |
||
042 | _apcc | ||
050 | 0 | 0 |
_aRM301.25 _b.N5 2004 |
060 | 1 | 0 |
_aQV 778 _bN576d 2004 |
082 | 0 | 0 |
_a615.19 _222 |
084 |
_a615.19 _bN D |
||
100 | 1 | _aNg, Rick. | |
245 | 1 | 0 |
_aDrugs _h[[Book] :] _bfrom discovery to approval / _cRick Ng. |
260 |
_aHoboken, N.J. : _bWiley-Liss, _cc2004. |
||
300 |
_axii, 355 p. : _bill. ; _c24 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
521 | _aAll Ages. | ||
650 | 0 | _aDrug development. | |
650 | 1 | 2 | _aTechnology, Pharmaceutical. |
650 | 2 | 2 | _aChemistry, Pharmaceutical. |
650 | 2 | 2 |
_aClinical Trials _xmethods. |
650 | 2 | 2 |
_aDrug Approval _xlegislation & jurisprudence. |
650 | 2 | 2 |
_aDrug Approval _xmethods. |
650 | 2 | 2 | _aDrug Design. |
650 | 2 | 2 |
_aDrug Industry _xmethods. |
700 | 1 | _aNg, Rick. | |
856 | 4 | 2 |
_3Contributor biographical information _uhttp://www.loc.gov/catdir/bios/wiley047/2003020804.html |
856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/description/wiley041/2003020804.html |
856 | 4 | 1 |
_3Table of contents _uhttp://www.loc.gov/catdir/toc/wiley041/2003020804.html |
906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
925 | 0 |
_aacquire _b1 shelf copy _xpolicy default |
|
955 |
_aNLM _ajc03 2003-09-24 to jc01; _djc01 2003-09-24 _ejc03 2003-09-24 to Dewey _aaa07 2003-09-25 _aps11 2004-02-12 1 copy rec'd., to CIP ver. _fjc03 2004-02-18 _gjc03 2004-02-18 to BCCD |
||
985 |
_aNLMCIP _d2003-09-24 |
||
991 |
_br-SciRR _hRM301.25 _i.N5 2004 _tCopy 1 _wGenBib |
||
001 | 0000025741 | ||
003 | 0000 | ||
942 | _cBK | ||
999 |
_c54609 _d54609 |